Pulmatrix Inc (PULM): said Robert W. Clarke, Ph.D., chief exec...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	9
Posts	836
Boards Moderated	0
Alias Born	06/24/2014

Kabuli

Re: stock1ace1 post# 1911

Monday, 06/25/2018 1:12:49 AM

Monday, June 25, 2018 1:12:49 AM

said Robert W. Clarke, Ph.D., chief executive officer of Pulmatrix. "There is no imminent plan to implement a reverse stock split. Pulmatrix has several important milestones ahead of us that management believes can and should drive shareholder value. Specifically:

Pulmazole is on target for our data readout. We will announce results as soon as it is appropriate based on data review.
PUR1800 is moving forward in non-clinical safety testing with a P2a study in COPD targeted for next year.
With our partner for the US (Vectura), we are targeting a P1/2 in COPD to start around year end.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PULM News

Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:06:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:00:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 02:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:05:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 01:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 08:05:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:05:21 PM